Medicamen Biotech Limited (BOM:531146)
India · Delayed Price · Currency is INR 319.05
+10.15 (3.29%)
At close: Sep 25, 2026
Medicamen Biotech Market Cap
Medicamen Biotech has a market cap or net worth of 4.33 billion as of September 25, 2026. Its market cap has increased by 2.77% in one year.
Market Cap
4.33B
Enterprise Value
4.49B
Revenue
2.06B
Ranking
n/a
PE Ratio
42.83
Stock Price
319.05
ChartMarket Cap Chart
Since January 12, 2005, Medicamen Biotech's market cap has increased from 108.49M to 4.33B, an increase of 3,888.63%. That is a compound annual growth rate of 18.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 4.33B | -6.26% |
| Dec 31, 2025 | 4.62B | -28.94% |
| Dec 31, 2024 | 6.50B | -14.77% |
| Dec 29, 2023 | 7.62B | -27.09% |
| Dec 30, 2022 | 10.45B | -3.50% |
| Dec 31, 2021 | 10.83B | 86.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kilitch Drugs (India) | 7.82B |
| ZIM Laboratories | 7.41B |
| Albert David | 4.97B |
| Trident Lifeline | 4.87B |
| Jenburkt Pharmaceuticals | 4.19B |
| Astonea Labs | 3.55B |
| Ambalal Sarabhai Enterprises | 3.11B |
| Sat Kartar Life | 2.96B |